Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions.
- DOI
- 10.1186/s40360-026-01234-9
- Published
- 2026 Sep 23
- Container
- BMC pharmacology & toxicology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40360-026-01234-9,
title = {Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions.},
author = {Guan Z and Chen M and Wei B and Su J and Tan D and Ke J and Huang G},
year = {2026},
journal = {BMC pharmacology \& toxicology},
doi = {10.1186/s40360-026-01234-9},
url = {https://doi.org/10.1186/s40360-026-01234-9}
}RIS
TY - JOUR TI - Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions. AU - Guan Z AU - Chen M AU - Wei B AU - Su J AU - Tan D AU - Ke J AU - Huang G PY - 2026 JO - BMC pharmacology & toxicology DO - 10.1186/s40360-026-01234-9 UR - https://doi.org/10.1186/s40360-026-01234-9 ER -
APA
Z, G., M, C., B, W., J, S., D, T., J, K., & G, H. (2026). Pharmacokinetic and bioequivalence evaluation of teneligliptin hydrobromide tablets following single-dose administration in healthy Chinese volunteers under fasting and fed conditions.. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-026-01234-9
Source records
- pubmed · retrieved 2026-11-10T14:53:41.897Z